Literature DB >> 20619467

Increased type 1 chemokine expression in experimental Chagas disease correlates with cardiac pathology in beagle dogs.

Paulo M M Guedes1, Vanja M Veloso, André Talvani, Livia F Diniz, Ivo S Caldas, Maria A Do-Valle-Matta, Juliana Santiago-Silva, Egler Chiari, Lucia M C Galvão, João S Silva, Maria T Bahia.   

Abstract

Chemokines and chemokine receptors interaction have presented important role in leukocyte migration to specific immune reaction sites. Recently, it has been reported that chemokine receptors CXC (CXCR3) and CC (CCR5) were preferentially expressed on Th1 cells while CCR3 and CCR4 were preferentially expressed on Th2 cells. This study evaluated the mRNA expression of type 1 and type 2 chemokine and chemokine receptors in the cardiac tissue of Beagle dogs infected with distinct genetic groups of Trypanosoma cruzi (Y, Berenice-78 and ABC strains) during acute and chronic phases. To analyze the correlation between chemokine and chemokine receptors expression and the development of heart pathology, the chronic infected animals were divided into groups, according to the parasite strain and based on the degree of heart damage: cardiac and indeterminate form of Chagas disease. Our results indicated that cardiac type1/2 chemokines and their receptors were partially dependent on the genetic diversity of parasites as well as the polarization of clinical forms. Also, dogs presenting cardiac form showed lower heart tissue mRNA expression of CCL24 (type 2) and higher expression of CCL5, CCL4 and CXCR3 (type 1) when compared with those with indeterminate form of disease. Together, these data reinforce a close-relation between T. cruzi genetic population and the host specific type 1 immune response and, for the first time, we show the distribution of type 1/2 chemokines associated with the development of cardiac pathology using dogs, a well similar model to study human Chagas disease.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20619467     DOI: 10.1016/j.vetimm.2010.06.010

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN: 0165-2427            Impact factor:   2.046


  11 in total

1.  Low doses of simvastatin therapy ameliorate cardiac inflammatory remodeling in Trypanosoma cruzi-infected dogs.

Authors:  Lilian Melo; Ivo Santana Caldas; Maíra Araújo Azevedo; Karolina Ribeiro Gonçalves; Alvaro Fernando da Silva do Nascimento; Vivian Paulino Figueiredo; Lívia de Figueiredo Diniz; Wanderson Geraldo de Lima; Rosália Moraes Torres; Maria Terezinha Bahia; André Talvani
Journal:  Am J Trop Med Hyg       Date:  2011-02       Impact factor: 2.345

2.  Visceral leishmaniasis: a practical strategy for quantitative molecular diagnosis in naturally infected dogs.

Authors:  Sérgio Caldas; Andreza P Marcelino; Gilson Faria; Fernanda de Oliveira Silva; Ana Caroline Zampiroli Ataide; Lucas Maciel Cunha; Maria Terezinha Bahia; Gustavo Fontes Paz; Célia M F Gontijo
Journal:  Parasitol Res       Date:  2020-04-14       Impact factor: 2.289

Review 3.  Interferon-γ and other inflammatory mediators in cardiomyocyte signaling during Chagas disease cardiomyopathy.

Authors:  Ludmila Rodrigues Pinto Ferreira; Amanda Farage Frade; Monique Andrade Baron; Isabela Cunha Navarro; Jorge Kalil; Christophe Chevillard; Edecio Cunha-Neto
Journal:  World J Cardiol       Date:  2014-08-26

4.  Domestic Pig (Sus scrofa) as an Animal Model for Experimental Trypanosoma cruzi Infection.

Authors:  Verónica Yauri; Yagahira E Castro-Sesquen; Manuela Verastegui; Noelia Angulo; Fernando Recuenco; Ines Cabello; Edith Malaga; Caryn Bern; Cesar M Gavidia; Robert H Gilman
Journal:  Am J Trop Med Hyg       Date:  2016-02-29       Impact factor: 2.345

Review 5.  Modulation of paraoxonases during infectious diseases and its potential impact on atherosclerosis.

Authors:  Ayman Samir Farid; Yoichiro Horii
Journal:  Lipids Health Dis       Date:  2012-07-23       Impact factor: 3.876

6.  Canine Macrophage DH82 Cell Line As a Model to Study Susceptibility to Trypanosoma cruzi Infection.

Authors:  Pedro Henrique Braz Mendonça; Raphael Francisco Dutra Barbosa da Rocha; Julliane Brito de Braz Moraes; Isabel Ferreira LaRocque-de-Freitas; Jorgete Logullo; Alexandre Morrot; Marise Pinheiro Nunes; Celio Geraldo Freire-de-Lima; Debora Decote-Ricardo
Journal:  Front Immunol       Date:  2017-05-31       Impact factor: 7.561

7.  Myocardial chemokine expression and intensity of myocarditis in Chagas cardiomyopathy are controlled by polymorphisms in CXCL9 and CXCL10.

Authors:  Luciana Gabriel Nogueira; Ronaldo Honorato Barros Santos; Barbara Maria Ianni; Alfredo Inácio Fiorelli; Eliane Conti Mairena; Luiz Alberto Benvenuti; Amanda Frade; Eduardo Donadi; Fabrício Dias; Bruno Saba; Hui-Tzu Lin Wang; Abilio Fragata; Marcelo Sampaio; Mario Hiroyuki Hirata; Paula Buck; Charles Mady; Edimar Alcides Bocchi; Noedir Antonio Stolf; Jorge Kalil; Edecio Cunha-Neto
Journal:  PLoS Negl Trop Dis       Date:  2012-10-25

8.  Genetic Susceptibility to Cardiac and Digestive Clinical Forms of Chronic Chagas Disease: Involvement of the CCR5 59029 A/G Polymorphism.

Authors:  Amanda Priscila de Oliveira; Cássia Rubia Bernardo; Ana Vitória da Silveira Camargo; Luiz Sérgio Ronchi; Aldenis Albaneze Borim; Cinara Cássia Brandão de Mattos; Eumildo de Campos Júnior; Lílian Castiglioni; João Gomes Netinho; Carlos Eugênio Cavasini; Reinaldo Bulgarelli Bestetti; Luiz Carlos de Mattos
Journal:  PLoS One       Date:  2015-11-23       Impact factor: 3.240

Review 9.  Chagas disease cardiomyopathy: immunopathology and genetics.

Authors:  Edecio Cunha-Neto; Christophe Chevillard
Journal:  Mediators Inflamm       Date:  2014-08-19       Impact factor: 4.711

10.  Doxycycline and Benznidazole Reduce the Profile of Th1, Th2, and Th17 Chemokines and Chemokine Receptors in Cardiac Tissue from Chronic Trypanosoma cruzi-Infected Dogs.

Authors:  Guilherme de Paula Costa; Laís Roquete Lopes; Maria Cláudia da Silva; Aline Luciano Horta; Washington Martins Pontes; Cristiane M Milanezi; Paulo Marcos da Mata Guedes; Wanderson Geraldo de Lima; Richard Schulz; João Santana da Silva; Andre Talvani
Journal:  Mediators Inflamm       Date:  2016-09-01       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.